Sanofi touts whooping cough vaccine

Sanofi Pasteur is touting a new study of its whopping cough vaccine which shows it is safe and effective. Cases of whooping cough have been surging in the US, and Sanofi expects to get FDA approval for marketing the vaccine next month. The vaccine is already available in Canada. Sanofi says that Adacel is 83 percent effective in preventing whooping cough in adolescents and adults.  

- read this story from The Boston Globe

Suggested Articles

A phase 3 study of NuCana’s lead drug was halted because a monitoring committee deemed it unlikely to succeed.

The filing follows data from Japanese phase 3 trials that assessed the oral HIF-PHI in chronic kidney disease patients.

The Allen Institute found major differences in human and mouse brain cells, which could guide the design of drugs for brain diseases.